NCT00757003

Brief Summary

PURPOSE OF RESEARCH: Endovascular stent-graft repair of aortic pathologies is a minimally-invasive alternative to open surgery that may decrease morbidity and mortality, particularly in high risk patients. Optimal patient selection, based on pathology and anatomy, is being defined. Technically successful implantation requires adequate assessment of pathology and anatomy, and development and execution of novel and delicate procedures that resolve the pathology while minimizing morbidity and mortality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Oct 2001

Longer than P75 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2001

Completed
7 years until next milestone

First Submitted

Initial submission to the registry

September 18, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 22, 2008

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

March 1, 2017

Completed
Last Updated

March 1, 2017

Status Verified

January 1, 2017

Enrollment Period

11.8 years

First QC Date

September 18, 2008

Results QC Date

January 10, 2017

Last Update Submit

January 10, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage of Participants With Technically Successful Implant

    The percentage of participants with technically successful implantation as assessed by the investigator is reported.

    Day 0 to Day 30

Secondary Outcomes (2)

  • Count of Participants Experiencing at Least One Endoleak Following Procedure

    Up to 60 months following procedure

  • Overall Survival

    60 months

Study Arms (1)

Treatment Arm - Placement of TAG device

EXPERIMENTAL

A TAG device will be used to repair the pathology in the thoracic aorta

Device: Endovascular Stent-graft repair of descending thoracic aorta

Interventions

A TAG device will be used to repair the pathology in the thoracic aorta

Treatment Arm - Placement of TAG device

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients should be poor or high risk open surgical candidates.
  • Anatomy meets TAG Endoprosthesis specification criteria.
  • Minimum 2 cm non-aneurysmal segment proximal and distal to the aneurysm
  • \<60 angle in the aortic arch may require additional length of non-aneurysmal segment is the arch is included in the treatment segment.
  • Ability to comply with protocol requirements including follow-up.
  • Signed Informed Consent

You may not qualify if:

  • \>4mm aortic taper and inability to use devices of different diameters, to compensate for the taper, in the treatment area of the aorta.
  • Significant thrombus at the proximal or distal implantation sites.
  • Planned occlusion of the left carotid or celiac arteries, unless supplemental conduit or alternate perfusion routes for end organ(s) provided.
  • Degenerative connective tissue disease, e.g. Marfan's or Ehler's Danlos Syndrome, unless the proximal and distal implantation sites of the TAG Endoprosthesis are located with in previous surgical grafts.
  • \. Female of child bearing age with positive pregnancy test.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University School of Medicine

Stanford, California, 94305, United States

Location

MeSH Terms

Conditions

Aortic DissectionAortic Aneurysm, Thoracic

Condition Hierarchy (Ancestors)

Dissection, Blood VesselAneurysmVascular DiseasesCardiovascular DiseasesAcute Aortic SyndromeAortic DiseasesAortic Aneurysm

Results Point of Contact

Title
Dr. Daniel Sze, Principal Investigator
Organization
Stanford University

Study Officials

  • Daniel Yung-Ho Sze

    Stanford University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

September 18, 2008

First Posted

September 22, 2008

Study Start

October 1, 2001

Primary Completion

July 1, 2013

Study Completion

May 1, 2014

Last Updated

March 1, 2017

Results First Posted

March 1, 2017

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will share

Data is made available upon request to colleagues conducting similar studies throughout the US.

Locations